Glycosaminoglycan Content in Term and Preterm Milk during the First Month of Lactation. by Coppa, Gv et al.
  
 
 
This is an author version of the contribution published on: 
 
 [Neonatology, vol. 101, issue 1 2012, DOI: 10.1159/000330848] 
The definitive version is available at: 
 
[http://www.karger.com/Article/FullText/330848] 
 
Neonatology  - Short Communication 
1594 words 
1 
Glycosaminoglycan content in term and preterm milk during the first month of 1 
lactation 2 
1Giovanni V. Coppa, 1Orazio Gabrielli, 1Lucia Zampini, 1Tiziana Galeazzi, 2Francesca 3 
Maccari, 2Dania Buzzega, 2Fabio Galeotti, 3Enrico Bertino, 2Nicola Volpi 4 
 5 
1Pediatric Division, Department of Clinical Sciences, Polytechnic University of Marche, 6 
Ospedali Riuniti, Presidio Salesi, Ancona, Italy (Prof. G.V. Coppa MD, Prof. O. 7 
Gabrielli MD, Dr. L. Zampini PhD. Dr. T. Galeazzi PhD); 8 
2Department of Biology, University of Modena & Reggio Emilia, Modena, Italy (Prof. 9 
N. Volpi PhD. Dr. F. Maccari PhD. Dr. D. Buzzega PhD. Dr. F. Galeotti PhD); 10 
3Neonatal Intensive Care Unit, Department of Pediatrics, University of Turin, Turin, 11 
Italy (Prof. Bertino MD). 12 
 13 
Contributors 14 
N.V. developed the applied methodologies. L.Z., T.G., F.M., D.B. and F.B. performed 15 
the experimental procedures and analyses. E.B. contributed in milk sample collection. 16 
N.V., G.V.C. and O.G. designed and developed the experimental design, performed 17 
data analysis and wrote the manuscript. 18 
All authors reviewed and approved the study.  19 
Conflicts of interest 20 
We declare that we have no conflicts of interest. 21 
Grant support 22 
None 23 
Running head  24 
Glycosaminoglycans in human milks 25 
Corresponding authors 26 
Prof. Nicola Volpi 27 
Department of Biology, Via Campi 213/D 28 
University of Modena & Reggio Emilia, 41100 Modena, Italy 29 
e-mail: volpi@unimo.it 30 
fax number: 0039 59 2055548 31 
tel number: 0039 59 2055543 32 
Neonatology  - Short Communication 
1594 words 
2 
 33 
Abstract 34 
Background. In a recent study, we performed a complete structural characterization 35 
of glycosaminoglycans (GAGs) in human mature milk. However, no data are available 36 
on the total content of GAGs in human milk from healthy mothers having delivered 37 
term or preterm newborns. 38 
Objectives. In this study, we evaluated the total content of GAGs in pooled milk 39 
from healthy mothers having delivered term or preterm newborns during the first month 40 
of lactation.  41 
Methods. Highly specific and sensitive analytical approaches were used to quantify 42 
human milk total GAGs. 43 
Results. Highest GAGs values are present at 4th day (~ 9.3 g/L and ~ 3.8 g/L in 44 
preterm and term milk, respectively), followed by a progressive decrease up to day 30th 45 
(~ 4.3 g/L and ~ 0.4 g/L ). The more remarkable differences are related to the first 46 
phases of lactation in which a strong decrease of GAGs was observed between days 4th 47 
and 10th (~-73% in term and ~-50% in preterm).  48 
Conclusions. During the first month of lactation the absolute amount of 49 
polysaccharides was constantly and significantly higher in preterm milk than in term 50 
one, with a similar behaviour in the decrease. These data further indicate that human 51 
milk GAGs may have an active role in protecting newborns during the first phases of 52 
lactation. 53 
 54 
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 56 
Introduction 57 
In a recent study [1], we performed a complete structural characterization of 58 
glycosaminoglycans (GAGs) in human mature milk in comparison with bovine milk. 59 
Quantitative analyses yielded 0.41 g/L of GAGs in human milk,  ~7 times more than in 60 
bovine milk. In particular, chondroitin sulfate (CS) and dermatan sulfate (DS), were 61 
found to differ considerably from one type of milk to the other. In fact, in human milk a 62 
low-sulfated CS was the main component (~56%), while DS was observed in very low 63 
amount (~2%). On the contrary, bovine milk was demonstrated to be composed of 64 
~66% DS and ~34% CS. Structural analysis also showed the presence of fast-moving 65 
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heparin (FM-Hep) that account for ~30-40% of total GAGs in both milk samples. The 66 
same research [1] offered the first full characterization of GAGs in human milk, 67 
providing useful data to gain a better understanding of their physiological role, as well 68 
as of their fundamental contribution to the health of the newborn. In fact, several types 69 
of microorganisms have also been demonstrated to use CS as receptors for the adhesion 70 
to and infection of host cells [1-3]. Furthermore, in human milk, Newburg et al. [4] 71 
demonstrated that CS or a CS-like moiety is able to inhibit the binding of the HIV 72 
envelop glycoprotein gp120 to the cellular CD4 receptor. From these studies it emerges 73 
that human milk GAGs, on the contrary of bovine milk, could play a role as soluble 74 
receptors. In fact, intact GAG molecules reach the small intestine, as no specific 75 
digestive enzyme able to degrade them is present on the intestinal wall. 76 
In this study, we evaluated the total content of GAGs in pooled milk from healthy 77 
mothers having delivered term or preterm newborns. To include in our study a relatively 78 
homogeneous but representative population we selected women who had both the 79 
Secretor and Lewis phenotypes, as determined in their saliva by the hemoagglutination-80 
inhibition test. This is the most common phenotype in Europe, as it is present in about 81 
70% of the general population [5]. Furthermore, we used pooled milk to have a robust 82 
characterization of the total content of GAGs. Additionally, we already observed no 83 
great variations between different term healthy mothers at the same time of lactation for 84 
the quali/quantitative composition of GAGs that was confirmed quite similar in all 85 
human Subjects [1].  86 
 87 
Results and Discussion 88 
Figure 1 illustrates agarose-gel eletrophoresis utilized to separate and quantify 89 
extracted GAGs from different milk samples. Both in term and preterm milk, GAGs 90 
showed a constant pattern essentially composed of two main polysaccharides, a low-91 
sulfated CS (~60-70%), FM-Hep (~30-40%) and quite no DS. Quantitative data are 92 
shown in Figure 2. As evident, considerable variation of GAGs concentration occurs 93 
during the first month of lactation. Highest values are present at 4th day (~ 9.3 g/L and ~ 94 
3.8 g/L in preterm and term milk, respectively), followed by a progressive decrease up 95 
to day 30th (~ 4.3 g/L and ~ 0.4 g/L ). The more remarkable differences are related to 96 
the first phases of lactation in which a strong decrease of GAGs was observed between 97 
days 4th and 10th (~-73% in term and ~-50% in preterm). During the first month of 98 
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lactation the absolute amount of polysaccharides was constantly and significantly higher 99 
in preterm milk than in term one, with a similar behaviour in the decrease. 100 
Comparative analysis of term and preterm milk demonstrate compositional 101 
differences in several of their nutritional components [6]. It is well known that several 102 
components show different behaviour during lactation. As regard as the carbohydrate 103 
component, dynamic variations were observed during the first month. In particular, 104 
lactose content increases both in term and preterm milk with higher concentration in the 105 
first. On the contrary, oligosaccharides decrease in both types of milk, with higher 106 
concentration in preterm milk [7, 8]. Very interestingly, the total amount of GAGs was 107 
higher in preterm than term milk, with a strong decrease after the first days of lactation, 108 
with the same trend already observed in oligosaccharides.  109 
Recent studies showed that some cell surface receptors are constituted by GAGs [2-110 
4], which in this way directly participate in infective and inflammatory processes. As a 111 
consequence, along with oligosaccharides, we can suppose that the high concentration 112 
of GAGs could be useful for the preterm newborn in defence processes against several 113 
pathogens (viruses, bacteria and their toxins) with a receptor-like mechanism preventing 114 
the adhesion of pathogens to epithelial cells. Furthermore, CS (and GAGs) is a well 115 
known antioxidant and antiinflammatory agent [9] and remarkably, for preterm infants 116 
endowed with an immature antioxidant defense system [10], GAGs may have important 117 
antioxidant properties. In fact, babies being exclusively fed with mother’s milk develop 118 
less oxidative stress than babies nourished with formula [11], and colostrum possesses 119 
relevant antiinfective and antioxidant properties contributing to the infant’s defense 120 
against free radicals generated by oxygen administration, infection, or byproducts of 121 
nutrient metabolism. In conclusion, further effords should be addressed to improve our 122 
knowledge not only on GAGs composition and structure but also on their role in 123 
physiological and pathological conditions. 124 
 125 
Materials and methods 126 
A morning milk sample was obtained with an electric breast pump at 4, 10, 20, and 127 
30 post-partum days from 18 women who delivered at term and from 26 women who 128 
delivered between 27th and 35th week of gestation.  129 
GAGs were extracted and quantified by analytical procedures reported in details in 130 
Coppa et al. [1]. 5 mL of milk were defatted with acetone. After centrifugation at 131 
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10,000 g for 10 min and drying at 60°C for 24 h, the pellet was solubilized in 20 mL of 132 
100 mM Na-acetate buffer pH 5.5 containing 5 mM EDTA and 5 mM cysteine. 200 mg 133 
of papain were added and the solution incubated for 24 h at 60°C in a stirrer. After 134 
boiling for 10 min, the mixture was centrifuged at 5,000 g for 15 min, and three 135 
volumes of ethanol saturated with sodium acetate were added to the supernatant. After 136 
storing at +4°C for 24 h, the precipitate was recovered by centrifugation at 5,000 g for 137 
15 min and dried at 60°C for 6 h. The dried precipitate was dissolved in 20 ml of 50 138 
mM NaCl and after centrifugation at 10,000 g for 10 min, the supernatant was applied 139 
to a column (2 cm x 7 cm) packed with QAE Sephadex® A-25 anion-exchange resin 140 
equilibrated with the same NaCl solution. GAGs were eluted with a linear gradient of 141 
NaCl from 50 mM to 1.2 M from 0 to 150 min using low-pressure liquid 142 
chromatography (Biologic LP chromatography system from BioRad) at a flow of 1 143 
ml/min. Fractions positive to uronic acid assay [1] were collected. Three volumes of 144 
ethanol saturated with sodium acetate were added to the pooled fractions and stored at 145 
+4°C for 24 h. The precipitate was recovered by centrifugation and dried at 60°C for 12 146 
h. The dried precipitate was dissolved in 100 µL distilled water and further analyzed. 147 
Quantitative agarose-gel electrophoresis in barium acetate/1,2-diaminopropane was 148 
performed essentially as previously reported elsewhere [1]. 149 
 150 
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Legends to Figures 188 
 189 
Figure 1. Agarose-gel electrophoresis of GAGs from human milk samples at different 190 
days of lactation in mothers delivering term and preterm newborns. CS: chondroitin 191 
sulfte. DS: dermatan sulfate HS: heparan sulfate. St: mix of CS, DS and HS. The 192 
suddivision in GAG species CS, DS and HS is just related to the standard. 193 
 194 
Figure 2. Total amount of GAGs in human milk during different days of lactation in 195 
mothers delivering term and preterm newborns. A curve illustrating the polysaccharides 196 
content trend is also reported for each type of milk. Data are reported as mean ± SD. 197 
198 
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